z-logo
open-access-imgOpen Access
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
Author(s) -
Hilary A. Robbins,
Aida Ferreiro-Iglesias,
Tim Waterboer,
Nicole Brenner,
Mari Nygård,
Noemi Bender,
Lea Schroeder,
Allan Hildesheim,
Michael Pawlita,
Gypsyamber D’Souza,
Kala Visvanathan,
Hilde Langseth,
Nicolas F. Schlecht,
Lesley F. Tinker,
Ilir Agalliu,
Sylvia WassertheilSmoller,
Eivind NessJensen,
Kristian Hveem,
Sara Grioni,
Rudolf Kaaks,
MaríaJosé Sánchez,
Elisabete Weiderpass,
Graham G. Giles,
Roger L. Milne,
Qiuyin Cai,
William J. Blot,
Wei Zheng,
Stephanie J. Weinstein,
Demetrius Albanes,
WenYi Huang,
Neal D. Freedman,
Aimée R. Kreimer,
Mattias Johansson,
Paul Brennan
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.21.01785
Subject(s) - medicine , serostatus , cancer , cohort , population , absolute risk reduction , serology , odds ratio , risk factor , epidemiology , cohort study , gynecology , immunology , confidence interval , antibody , human immunodeficiency virus (hiv) , environmental health , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom